Interleukin-1α-induced tumour pathophysiologies can be exploited with bioreductive alkylating agents

Conference proceeding

Peer reviewed

P. G BRAUSCHWEIGER, S. A JONES, C. S JOHNSON and P FRUMANSKI

International journal of radiation biology (Print), Vol.60(1-2), pp.369-372

Vasculature as a target for anti-cancer therapy, Manchester, 17-21 september 1990

1991

PMID: 1677996

Abstract

Biological and medical sciences

Medical sciences

Antineoplastic agents

Combined treatments (chemotherapy of immunotherapy associated with an other treatment)

Pharmacology. Drug treatments

6 Record Views

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.102 Stem Cell Research; 1.102.996 HIF-1 Alpha
Web Of Science research areas: Biology; Nuclear Science & Technology; Radiology, Nuclear Medicine & Medical Imaging
ESI research areas: Biology & Biochemistry

This output has contributed to the advancement of the following goals:

Source: InCites

Title: Interleukin-1α-induced tumour pathophysiologies can be exploited with bioreductive alkylating agents
Creators: P. G BRAUSCHWEIGER - Univ. Miami, Sylvester cancer cent., dep. radiation oncology, Miami FL 33101, United States
S. A JONES - Univ. Miami, Sylvester cancer cent., dep. radiation oncology, Miami FL 33101, United States
C. S JOHNSON - Univ. Miami, Sylvester cancer cent., dep. radiation oncology, Miami FL 33101, United States
P FRUMANSKI - Univ. Miami, Sylvester cancer cent., dep. radiation oncology, Miami FL 33101, United States
Publication Details: International journal of radiation biology (Print), Vol.60(1-2), pp.369-372
Conference: Vasculature as a target for anti-cancer therapy, Manchester, 17-21 september 1990
Publisher: Taylor & Francis; London
Grant note: L. H. Gray memorial trust
Language: English
Resource Type: Conference proceeding
PMID: 1677996
Record Identifier: 991031577169602976